Abstract
Purpose
The debate about the impact of intensified hyperglycemia treatment is still ranging. The main objective was to assess whether intensive glycemic control in hospitalized diabetic patients undergoing a liver transplant is associated with a lower rate of graft rejection at 3 months and at 5 years post-transplant.
Methods
Cross-sectional study comparing a cohort of patients undergoing liver transplant in 2010 and 2011, in whom an intensive insulin protocol was applied, with a retrospective group of patients undergoing a liver transplant in 2005 and 2006, in whom a conventional insulin protocol was applied. Both diabetics and non-diabetics were compared. As intensive insulin therapy is applied mainly in diabetic patients, it is expected that, when comparing both periods, the treatment would only benefit those patients.
Results
The logistic regression model showed a statistically significant interaction between the treatment group and the presence of diabetes for the rejection rate 3 months and 5 years post-transplant. At both time points, the intensive insulin treatment group had lower rejection rates in the case of diabetic patients, which did not occur in non-diabetic patients.
Conclusions
Our study shows a decrease in the rate of liver graft rejection in diabetic patients undergoing intensive insulin treatment.
Similar content being viewed by others
Abbreviations
- BMI:
-
Body mass index
- HCC:
-
Hepatocellular carcinoma
- HCV:
-
Hepatitis C virus
- ICU:
-
Intensive care unit
References
Clement S, Braithwaite SS, Magee MF, Ahmann A, Smith EP, Schafer RG, Hirsch IB (2004) Management of diabetes and hyperglycemia in hospitals. Diabetes Care 27:553–591
Inzucchi SE (2006) Clinical practice. Management of hyperglycemia in the hospital setting. N Engl J Med 355:1903–1922
Candelise L, Landi G, Orazio EN, Boccardi E (1985) Prognostic significance of hyperglycemia in acute stroke. Arch Neurol 42:661–663
Woo J, Lam CW, Kay R, Wong AH, Teoh R, Nicholls MG (1990) The influence of hyperglycemia and diabetes mellitus on immediate and 3-months morbidity and mortality after acute stroke. Arch Neurol 47:1174–1177
Malmberg K, Rydén L, Efendic S, Herlitz J, Nicol P, Waldenström A, Wedel H, Welin L (1995) Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 26:57–65
Weir CJ, Murray GD, Dyker AG, Lees KR (1997) Is hyperglycemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study. BMJ 314:1303–1306
Pomposelli JJ, Baxter JK III, Babineau TJ, Pomfret EA, Driscoll DF, Forse RA, Bistrian BR (1998) Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. JPEN J Parenter Enteral Nutr 22:77–81
Malmberg K, Norhammar A, Wedel H, Rydén L (1999) Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 99:2626–2632
Capes SE, Hunt D, Malmberg K, Gerstein HC (2000) Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systemic overview. Lancet 355:773–778
Gore DC, Chinkes D, Heggers J, Herndon DN, Wolf SE, Desai M (2001) Association of hyperglycemia with increased mortality after severe burn injury. J Trauma 51:540–544
Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC (2001) Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 32:2426–2432
Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE (2002) Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 87:978–982
Krinsley JS (2003) Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 78:1471–1478
Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359–1367
Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R (2006) Intensive insulin therapy in the medical ICU. N Engl J Med 354:449–461
Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K, German Competence Network Sepsis (SepNet) (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358:125–139
Krinsley JS (2004) Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 79:992–1000
Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hébert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ, NICE-SUGAR study investigators (2009) Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360:1283–1297
Griesdale DE, de Souza RJ, van Dam RM, Heyland DK, Cook DJ, Malhotra A, Dhaliwal R, Henderson WR, Chittock DR, Finfer S, Talmor D (2009) Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 180:821–827
Hashimoto M, Sugarawa Y, Tamura S, Kaneko J, Matsui Y, Togashi J, Makuuchi M (2008) Bloodstream infection after living donor transplantation. Scand J Infect Dis 40:509–516
Samuelson AL, Lee M, Kamal A, Keeffe EB, Ahmed A (2010) Diabetes mellitus increases the risk of mortality following liver transplantation independent of MELD score. Dig Dis Sci 55:2089–2094
Ammori JB, Sigakis M, Englesbe MJ, O´Reilly M, Pelletier SJ (2007) Effect of intraoperative hyperglycemia during liver transplantation. J Surg Res 140:227–233
Park C, Hsu C, Neelekanta G, Nourmand H, Braunfeld M, Wray C, Steadman RH, Hu KQ, Cheng RT, Xia VW (2009) Severe intraoperative hyperglycemia is independently associated with surgical site infection after liver transplantation. Transplantation 87:1031–1036
Wallia A, Parikh ND, Molitch ME, Mahler E, Tian L, Huang JJ, Levitsky J (2010) Posttransplant hyperglycemia is associated with increased risk of liver allograft rejection. Transplantation 89:222–226
Keegan MT, Vrchota JM, Haala PM, Timm JV (2010) Safety and effectiveness of intensive insulin protocol use in post-operative liver transplant recipients. Transplant Proc 42:2617–2624
Merino Torres JF (2009) Manual de atención al diabético hospitalizado. 1ª edición. Madrid. ISBN 9788469277010
American Diabetes Association (2014) Standards of medical care in diabetes-2014. Diabetes Care 37(Suppl 1):S14–S80
Cacciatore L, Cozzolino G, Giardina MG, De Marco F, Sacca L, Esposito P, Francica G, Lonardo A, Matarazzo M, Varriale A (1988) Abnormalities of glucose metabolism induced by liver cirrhosis and glycosylated hemoglobin levels in chronic liver disease. Diabetes Res 7:185–188
Nomura Y, Nanjo K, Miyano M, Kikuoka H, Kuriyama S, Maeda M, Miyamura K (1989) Hemoglobin A1 in cirrhosis of the liver. Diabetes Res 11:177–180
John PR, Thuluvath PJ (2001) Outcome of liver transplantation in patients with diabetes mellitus: a case-control study. Hepatology 34:889–895
Hsaiky LM, Bajjoka IE, Patel D, Aboulijoud MS (2007) Postoperative use of intense insulin therapy in liver transplant recipients. Am J Transplant 7(S2):194
Hsaiky LM, Bajjoka IE, Patel D, Aboulijoud MS (2008) Postoperative use of intense therapy in liver transplant recipients. Am J Transplant 8(S2):260
The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986
Turner RC, Cull CA, Frighi V, Holman RR (1999) Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 81:2005–2012
Morigi M, Angioletti S, Imberti B, Donadelli R, Micheletti G, Figliuzzi M, Remuzzi A, Zoja C, Remuzzi G (1998) Leucocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion. J Clin Invest 101:1905–1915
Takami S, Yamashita S, Kihara S, Kameda-Takemura K, Matsuzawa Y (1998) High concentration of glucose induces the expression of intercellular adhesion molecule-1 in human umbilical vein endothelial cells. Atherosclerosis 138:35–41
Fernández-Real JM, Ricart W (1999) Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftiness. Diabetologia 42:1367–1374
Pavlovic D, van de Winkel M, van der Auwera B, Chen MC, Schuit F, Bouwens L, Pipeleers D (1997) Effect of interferon-gamma and glucose on major histocompatibility complex class I and class II expression by pancreatic beta- and non-beta-cells. J Clin Endocrinol Metab 82:2329–2336
Podrazik RM, Natale JE, Zelenock GB, D´Aleoy LG (1989) Hyperglycemia exacerbates and insulin fails to protect in acute renal ischemia in the rat. J Surg Res 46:572–578
Bulles Montaño CE, Montoya JF, Londoño CA, Palacios Bayona KL, Restrepo Gutiérrez JC, Restrepo JG, Arango Toro CM, Jaimes Barragan FA (2014) Complications associated with hyperglycemia in liver transplant patients. Rev Gastroenterol Mex 79:180–186
Panés J, Kurose I, Rodriguez-Vaca D, Anderson DC, Miyasaka M, Tso P, Granger DN (1996) Diabetes exacerbates inflammatory responses to ischemia-reperfusion. Circulation 93:161–167
Parekh J, Niemann CU, Dang K, Hirose R (2011) Intraoperative hyperglycemia augments ischemia reperfusion injury in renal transplantation: a prospective study. J Transplant 2011:652458
Acknowledgements
Agustín Ramos-Prol and Juan Francisco Merino-Torres are the guarantors of this work and, as such, had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Funding
The authors received no financial support for this study.
Author information
Authors and Affiliations
Contributions
AR-P Principal author, patient visits, testing, data collection. DH-M bioestatistical analysis. BR-M help in search for patients, application of liver transplant protocols. MR-A help in data collection. MB help in coordination, help in search for patients, application of liver transplant protocols. ÁM-H help in search for patients, application of surgery and liver transplant protocols. JFM-T help in coordination, help in analysis and discussion, and help in data collection.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
For this type of study formal consent is not required.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Ramos-Prol, A., Hervás-Marín, D., Rodríguez-Medina, B. et al. Intensified blood glucose treatment in diabetic patients undergoing a liver transplant: impact on graft evolution at 3 months and at 5 years. J Endocrinol Invest 41, 821–829 (2018). https://doi.org/10.1007/s40618-017-0810-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-017-0810-z